BIOQUAL, Inc.
BIOQ
$37.51
-$0.19-0.50%
OTC PK
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -7.50% | -14.29% | -16.59% | -22.05% | -18.36% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -7.50% | -14.29% | -16.59% | -22.05% | -18.36% |
| Cost of Revenue | -17.61% | -17.53% | -14.64% | -16.42% | -14.38% |
| Gross Profit | 57.09% | 1.24% | -24.14% | -43.99% | -37.07% |
| SG&A Expenses | -8.16% | -7.79% | -8.55% | -8.14% | -2.19% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -15.63% | -15.53% | -13.39% | -14.83% | -12.09% |
| Operating Income | 102.68% | 44.65% | -9,573.98% | -514.87% | -396.03% |
| Income Before Tax | 119.44% | 58.84% | -370.01% | -350.45% | -444.50% |
| Income Tax Expenses | 126.53% | 87.36% | -3,305.71% | -443.14% | -340.20% |
| Earnings from Continuing Operations | 116.25% | 43.03% | -316.79% | -322.25% | -509.31% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 116.25% | 43.03% | -316.79% | -322.25% | -509.31% |
| EBIT | 102.68% | 44.65% | -9,573.98% | -514.87% | -396.03% |
| EBITDA | 209.22% | 375.26% | -81.31% | -138.42% | -240.10% |
| EPS Basic | 116.25% | 43.03% | -316.78% | -322.25% | -509.32% |
| Normalized Basic EPS | 119.44% | 58.85% | -370.02% | -350.45% | -444.44% |
| EPS Diluted | 116.06% | 42.92% | -321.96% | -325.12% | -504.15% |
| Normalized Diluted EPS | 119.44% | 58.85% | -370.02% | -350.45% | -444.44% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Dividend Per Share | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Payout Ratio | 1.00% | -0.76% | -1.46% | -1.45% | 0.84% |